Exquisite Sequence Selectivity with Small Conditional RNAs
Source abstract
Abstract
Dynamic RNA nanotechnology based on programmable hybridization cascades with small conditional RNAs (scRNAs) offers a promising conceptual framework for engineering programmable conditional regulation in vivo. While single-base substitution (SBS) somatic mutations and single-nucleotide polymorphisms (SNPs) are important markers and drivers of disease, it is unclear whether synthetic RNA signal transducers are sufficiently programmable to accept a cognate RNA input while rejecting single-nucleotide sequence variants. Here, we explore the limits of scRNA programmability, demonstrating isothermal, enzyme-free genotyping of RNA SBS cancer markers and SNPs using scRNAs that execute a conditional hybridization cascade in the presence of a cognate RNA target. Kinetic discrimination can be engineered on a time scale of choice from minutes to days. To discriminate even the most challenging single-nucleotide sequence variants, including those that lead to nearly isoenergetic RNA wobble pairs, competitive inhibition with an unstructured scavenger strand or with other scRNAs provides a simple and effective principle for achieving exquisite sequence selectivity.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA and protein synthesis mechanisms · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Division of Biology and Biological Engineering, and ‡Division of Engineering and Applied Science, California Institute of Technology, Pasadena, California 91125, United States
Funding
Elsa U. Pardee Foundation · Gordon and Betty Moore Foundation · National Institutes of Health · National Science Foundation
References (19)
Show source-provided references
1. Bath J. · Nat. Nanotechnol. · 2007 · 2 · 27510.1038/nnano.2007.104 ↗
2. Zhang D. Y. · Nature Chem. · 2011 · 3 · 10310.1038/nchem.957 ↗
3. Liang J. C. · Mol. Cell · 2011 · 43 · 91510.1016/j.molcel.2011.08.023 ↗
4. Benenson Y. · Curr. Opin. Chem. Biol. · 2012 · 16 · 27810.1016/j.cbpa.2012.05.192 ↗
5. Stratton M. R. · Science · 2011 · 331 · 155310.1126/science.1204040 ↗
6. Kurman R. J. · Hum. Pathol. · 2011 · 42 · 91810.1016/j.humpath.2011.03.003 ↗
7. Manolio T. A. · J. Clin. Invest. · 2008 · 118 · 159010.1172/JCI34772 ↗
8. Trejo-de la O A. · Genes Immun. · 2014 · 15 · 19910.1038/gene.2014.10 ↗
9. Veigas B. · J. Nanobiotechnol. · 2013 · 11 · 3810.1186/1477-3155-11-38 ↗
10. Trembizki E. · J. Antimicrob. Chemother. · 2014 · 69 · 152610.1093/jac/dkt544 ↗
11. Mathews D. H. · J. Mol. Biol. · 1999 · 288 · 91110.1006/jmbi.1999.2700 ↗
12. Dirks R. M. · Proc. Natl. Acad. Sci. U.S.A. · 2004 · 101 · 1527510.1073/pnas.0407024101 ↗
13. Quartin R. S. · Biochemistry · 1989 · 28 · 867610.1021/bi00448a002 ↗
14. Yurke B. · Nature · 2000 · 406 · 60510.1038/35020524 ↗
15. Zhang H. Q. · Chem. Rev. · 2013 · 113 · 281210.1021/cr300340p ↗
16. Wang F. · Chem. Rev. · 2014 · 114 · 288110.1021/cr400354z ↗
17. Jung C. · Acc. Chem. Res. · 2014 · 47 · 182510.1021/ar500059c ↗
18. Choi H. M. T. · Nat. Biotechnol. · 2010 · 28 · 120810.1038/nbt.1692 ↗
19. Hochrein L. M. · J. Am. Chem. Soc. · 2013 · 135 · 1732210.1021/ja404676x ↗